Adverse events associated with medical cannabis reported within a centralized call center
Artículo
Material complementario disponible
Artículo
DOAJ
IntroductionThe use of medical cannabis products is expanding, yet real-world data on associated adverse events (AEs) remain limited. Controlled trials often exclude diverse patient populations and product types, making ...
LCC LCC:Therapeutics. PharmacologyIdioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario